Trade

with

Cynosure Inc
(NASDAQ: CYNO)
AdChoices
20.70
-0.16
-0.77%
After Hours :
20.70
0.00
0.00%

Open

20.84

Previous Close

20.86

Volume (Avg)

154.65k (192.00k)

Day's Range

20.58-21.14

52Wk Range

18.63-31.48

Market Cap.

451.48M

Dividend Rate ( Yield )

-

Beta

1.48

Shares Outstanding

21.64M

P/E Ratio (EPS)

41.15 (0.51)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 226.01M

    • Net Income

    • -1.65M

    • Market Cap.

    • 451.48M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 4.20

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.48

    • Forward P/E

    • -

    • Price/Sales

    • 1.71

    • Price/Book Value

    • 1.33

    • Price/Cash flow

    • 26.18

      • EBITDA

      • 3.28M

      • Return on Capital %

      • 2.74

      • Return on Equity %

      • 3.38

      • Return on Assets %

      • 2.74

      • Book Value/Share

      • 15.62

      • Shares Outstanding

      • 21.64M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 39.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 44.90

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 10.11

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 57.41

            • 64.08

            • Pre-Tax Margin

            • 5.48

            • 15.19

            • Net Profit Margin

            • 4.20

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 56.70

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -5.70

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -6.80

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.05

              • 0.34

              • Current Ratio

              • 3.61

              • 2.55

              • Quick Ratio

              • 2.44

              • 1.83

              • Interest Coverage

              • -

              • 11.70

              • Leverage Ratio

              • 1.26

              • 1.86

              • Book Value/Share

              • 15.62

              • 11.67

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 40.98

                • 35.09

                • P/E Ratio 5-Year High

                • 62.10

                • 224.03

                • P/E Ratio 5-Year Low

                • 17.36

                • 60.23

                • Price/Sales Ratio

                • 1.72

                • 3.24

                • Price/Book Value

                • 1.33

                • 3.29

                • Price/Cash Flow Ratio

                • 26.18

                • 19.05

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 3.38

                    (-3.60)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • 2.74

                    (-3.00)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • 3.30

                    (-3.60)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • 19.67k

                  • 34.11k

                  • Inventory Turnover

                  • 2.11

                  • 2.77

                  • Asset Turnover

                  • 0.65

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -5.83M
                  Operating Margin
                  -2.58
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  26.18
                  Ownership

                  Institutional Ownership

                  87.92%

                  Top 10 Institutions

                  41.11%

                  Mutual Fund Ownership

                  42.92%

                  Float

                  99.90%

                  5% / Insider Ownership

                  0.75%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Wells Fargo Advantage Emerging Gr Fund

                  •  

                    570,163

                  • -0.13

                  • 2.63

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    437,682

                  • 0.20

                  • 2.01

                  • LKCM Small Cap Eq Fund

                  •  

                    393,393

                  • 28.70

                  • 1.80

                  • AMG TimesSquare Small Cap Growth Fund

                  •  

                    390,000

                  • 8.88

                  • 1.80

                  • Loomis Sayles Small Cap Growth Fund

                  •  

                    337,696

                  • 8.80

                  • 1.56

                  • iShares Russell 2000 (AU)

                  •  

                    334,391

                  • -1.46

                  • 1.53

                  • Vanguard Total Stock Mkt Idx

                  •  

                    322,433

                  • 0.00

                  • 1.49

                  • Pru Ret Small Cap Growth/TimesSquare SP

                  •  

                    322,000

                  • 8.42

                  • 1.47

                  • Vanguard VIF Small Comp Gr

                  •  

                    261,499

                  • 0.00

                  • 1.20

                  • DFA U.S. Micro Cap Portfolio

                  •  

                    240,777

                  • 0.88

                  • 1.10

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • TimesSquare Capital Management, LLC

                  •  

                    1,241,565

                  • +16.58%

                  • 5.67

                  • BlackRock Fund Advisors

                  •  

                    1,187,983

                  • +2.50%

                  • 5.43

                  • Wells Fargo Bank NA

                  •  

                    1,060,542

                  • -12.40%

                  • 4.85

                  • Dimensional Fund Advisors, Inc.

                  •  

                    942,517

                  • +5.28%

                  • 4.31

                  • King Luther Capital Management Corp

                  •  

                    897,484

                  • +27.57%

                  • 4.10

                  • Thompson, Siegel & Walmsley LLC

                  •  

                    892,267

                  • +37.84%

                  • 4.08

                  • BROADWOOD CAPITAL INC

                  •  

                    817,029

                  • 0.00%

                  • 3.73

                  • Vanguard Group, Inc.

                  •  

                    703,973

                  • +1.14%

                  • 3.22

                  • ING Investment Management LLC

                  •  

                    642,402

                  • +12.90%

                  • 2.94

                  • Loomis Sayles & Company L.P.

                  •  

                    607,257

                  • +79.22%

                  • 2.78

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  Cynosure Inc was incorporated in July 1991. The Company develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive proc...moreedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus and ablate sweat glands. It has also developed an aesthetic treatment product for the home use market. The Company sells its products through a direct sales force in North America, France, Spain, the United Kingdom, Germany, Australia, Korea, China, Japan and Mexico and through international distributors in approximately 120 other countries. Its ...moreproduct portfolio is composed of various energy sources including Alexandrite, diode, Nd:YAG, picosecond, pulse dye, and Q-switched lasers and intense pulsed light. It offers single energy source systems as well as workstations that incorporate two or more different types of lasers or pulsed light technologies. It offers multiple technologies and system alternatives at various price points depending mainly on the number and type of energy sources included in the system. Its products are designed to be easily upgradeable to add additional energy sources and handpieces, which provide its customers with technological flexibility as they expand their practices. The Company’s latest innovations are SmartLipo system and PicoSure system. The Company’s flagship products include Elite, Affirm/SmartSkin, Cynergy, Accolade. The Company sells its aesthetic treatment systems to the traditional physician customer base of dermatologists and plastic surgeons as well as to non-traditional physician customers who are providing aesthetic services using laser and light-based technology. Non-traditional physician customers can include primary care physicians, obstetricians and gynecologists. As of December 31, 2013, the Company owns over 60 United States patents, as well as many United States pending applications and foreign patents and pending applications. It is also joint owners with El.En. of certain patents and pending applications. The Company competes with Cutera, Solta Medical, Syneron Medical, ZELTIQ Aesthetics, Alma Lasers among others. Its products are medical devices subject to extensive and rigorous regulation by the U.S. Food and Drug Administration, or FDA, as well as other regulatory bodies.lessless

                  Key People

                  Michael R. Davin

                  CEO/Chairman of the Board/Director

                  Timothy W. Baker

                  CFO/Chief Accounting Officer/COO/President/Treasurer

                  Douglas J. Delaney

                  Executive VP, Divisional

                  Ettore V. Biagioni

                  Director

                  Marina Hatsopoulos

                  Director

                  • Cynosure Inc

                  • 5 Carlisle Road

                  • Westford, MA 01886

                  • USA.Map

                  • Phone: +1 978 256-4200

                  • Fax: -

                  • cynosure.com

                  Incorporated

                  1991

                  Employees

                  576

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: